Connect with others who understand.

Sign up Log in
Resources
About MyLeukemiaTeam
Powered By

List of Treatments for Leukemia

Below is a listing of treatments and therapies for leukemia. Click on one to read more information or connect with others currently using it.

Neulasta (Pegfilgrastim)

Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections for people with certain types of cancer after receiving chemotherapy or some types… read more

Nipent (Pentostatin)

Overview
Nipent is a prescription medication approved by the U.S.Food and Drug Administration (FDA) to treat hairy cell leukemia in people with active disease. This drug is indicated in individuals with new hairy cell… read more

Novantrone (Mitoxantrone)

Overview
Novantrone is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemia (ANLL) in adults. Novantrone is also known by its drug name, mitoxantrone. The… read more

Nutrition

Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with leukemia, good nutrition can help you recover from treatment, reduce treatment side effects, support bone health,… read more

Oncaspar (Pegaspargase)

Overview
Oncaspar is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute lymphoblastic leukemia (ALL). Oncaspar is often used as a part of a chemotherapy regimen. Oncaspar… read more

Onureg (Azacitidine)

Overview
Onureg is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myeloid leukemia who achieved a first complete remission or complete remission with… read more

Radiation therapy

Overview
Radiation therapy (also called RT or radiotherapy) is not commonly used to treat leukemia. However, radiation therapy is used in some cases of acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia… read more

Revuforj (Revumenib)

Overview
Revuforj is approved by the U.S. Food and Drug Administration (FDA) for the treatment of relapsed or refractory acute leukemia in adults and children aged 1 year and older with a lysine methyltransferase 2A gene…

read more

Rituxan (Rituximab)

Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and several types of non-Hodgkin lymphoma in adults. It is also indicated for… read more

Rituxan Hycela (Rituximab/Hyaluronidase Human)

Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia and some types of lymphoma. Rituxan Hycela is usually prescribed together with… read more

Rydapt (Midostaurin)

Overview
Rydapt is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myelogenous leukemia (AML) that has tested positive for the FLT3 mutation. Rydapt is also… read more

Scemblix (Asciminib)

Overview
Scemblix is approved by the U.S. Food and Drug Administration (FDA) to treat adults with a type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia, or Ph+ CML, in its early stages…

read more

Splenectomy

Overview
Splenectomy is the surgical removal of the spleen, a small organ located on the left side of your abdomen, under the rib cage. A healthy spleen filters old or abnormal red blood cells out of the blood and… read more

Sprycel (Dasatinib)

Overview
Sprycel is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myeloid leukemia (CML) in the chronic phase who have tested positive for the Philadelphia… read more

Synribo (Omacetaxine mepesuccinate)

Overview
Synribo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic myeloid leukemia (CML) in the chronic or accelerated phase. Synribo is indicated in… read more

Tasigna (Nilotinib)

Overview
Tasigna is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults and children ages 1 year or older newly diagnosed with chronic myelogenous leukemia (CML) in the chronic… read more

Thioguanine

Overview
Thioguanine is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat acute nonlymphocytic leukemias. Thioguanine is often combined with other medications in a chemotherapy… read more

Tibsovo (Ivosidenib)

Overview
Tibsovo is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory acute myeloid leukemia (AML) that has tested positive for a mutation in… read more

Treanda (Bendamustine)

Overview
Treanda, also known by its drug name, bendamustine, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat chronic lymphocytic leukemia (CLL) and indolent B-cell… read more

Trisenox (Arsenic trioxide)

Overview
Trisenox is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating acute promyelocytic leukemia (APL) unresponsive to other forms of chemotherapy. Trisenox is reserved… read more

Vanflyta (Quizartinib)

Overview
Vanflyta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication (ITD)-positive. This drug…

read more

Venclexta (Venetoclax)

Overview
Venclexta is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). Venclexta is also… read more

Vincristine sulfate

Overview
Vincristine sulfate is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat several types of leukemia, including acute lymphoblastic leukemia (ALL). Vincristine sulfate is… read more

Vyxeos (Daunorubicin/Cytarabine)

Overview
Vyxeos is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with acute myeloid leukemia (AML) that developed after treatment for another type of cancer, known as… read more

Xospata (Gilteritinib)

Overview
Xospata is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory acute myelogenous leukemia (AML) that has tested positive for the FLT3… read more

Zydelig (Idelalisib)

Overview
Zydelig is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed cases of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular B-cell… read more

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in